Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 48 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 33 | 1,469−9.4%/yr | −9.4%/yr | 3.10.9× | 1% | 1,500 in 2030+0.4%/yr |
| Lumbar fusion | 33 | 1,251−4%/yr | −4%/yr | 2.60.8× | 1% | 1,500 in 2030+3.1%/yr |
| Cervical fusion & disc arthroplasty | 10 | 605−9.7%/yr | −9.7%/yr | 1.30.7× | 2% | 730 in 2030+3.1%/yr |
| Kyphoplasty & vertebroplasty | 5 | 575−12%/yr | −12%/yr | 1.20.7× | 21% | 690 in 2030+3%/yr |
| SI joint fusion | 2 | 100−6.4%/yr | −6.4%/yr | 0.20.6× | 0% | 170 in 2030+8.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 219 | 49,665−0.1%/yr | −0.1%/yr | 103.00.9× | 29% | 64,000 in 2030+4.3%/yr |
| Skin substitutes & wound grafts | 24 | 7,085+18%/yr | +18%/yr | 9.20.8× | 65% | 11,400 in 2030+8.3%/yr |
| Bone graft & orthobiologics | 7 | 228−18%/yr | −18%/yr | 0.50.7× | 0% | 260 in 2030+2.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 75 | 6,856−6.1%/yr | −6.1%/yr | 14.21.0× | 81% | 7,510 in 2030+1.5%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 14 | 792+1.1%/yr | +1.1%/yr | 1.61.2× | 17% | 700 in 2030−2%/yr |
| Spinal cord & DRG stimulation | 7 | 342−3.7%/yr | −3.7%/yr | 0.70.7× | 42% | 480 in 2030+5.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 22 | 2,281−6.3%/yr | −6.3%/yr | 4.70.7× | 43% | 2,570 in 2030+2%/yr |
| Dialysis access | 25 | 1,806−14%/yr | −14%/yr | 4.10.7× | 13% | 1,510 in 2030−3%/yr |
| Superficial venous ablation | 10 | 988−4.4%/yr | −4.4%/yr | 2.00.3× | 83% | 1,300 in 2030+4.7%/yr |
| Carotid revascularization | 15 | 796−5.1%/yr | −5.1%/yr | 1.71.3× | 0% | 760 in 2030−0.8%/yr |
| Thrombectomy, IVC filters & venous stents | 3 | 595+3.1%/yr | +3.1%/yr | 1.30.8× | 5% | 810 in 2030+5.2%/yr |
| Aortic endografts (EVAR/TEVAR) | 2 | 285−10%/yr | −10%/yr | 0.61.3× | 0% | 280 in 2030−0.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cholecystectomy & appendectomy | 56 | 2,519−8.1%/yr | −8.1%/yr | 5.71.3× | 1% | 2,490 in 2030−0.2%/yr |
| Hernia repair | 20 | 2,512−6.9%/yr | −6.9%/yr | 5.80.9× | 1% | 2,530 in 2030+0.1%/yr |
| Colorectal resection | 1 | 825−7.8%/yr | −7.8%/yr | 1.81.1× | 0% | 700 in 2030−2.7%/yr |
| Antireflux & hiatal hernia surgery | 6 | 403−5.9%/yr | −5.9%/yr | 0.91.1× | 0% | 430 in 2030+1%/yr |
| Breast reconstruction | 1 | 152−5.7%/yr | −5.7%/yr | 0.30.7× | 0% | 110 in 2030−4.6%/yr |
| Bariatric surgery | 1 | 103−21%/yr | −21%/yr | 0.21.2× | 0% | 80 in 2030−5.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 59 | 2,308−6.2%/yr | −6.2%/yr | 5.11.0× | 3% | 2,480 in 2030+1.2%/yr |
| BPH procedures | 16 | 1,515−6.7%/yr | −6.7%/yr | 3.30.7× | 23% | 1,270 in 2030−2.9%/yr |
| Hysterectomy, hysteroscopy & ablation | 13 | 1,108−5.7%/yr | −5.7%/yr | 2.71.0× | 9% | 950 in 2030−2.6%/yr |
| Incontinence, prolapse & sacral neuromodulation | 10 | 902−8.4%/yr | −8.4%/yr | 2.00.7× | 11% | 950 in 2030+0.9%/yr |
| Prostatectomy & nephrectomy | 5 | 358−1.2%/yr | −1.2%/yr | 0.90.7× | 0% | 390 in 2030+1.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 10 | 1,177−7.5%/yr | −7.5%/yr | 2.60.5× | 88% | 1,340 in 2030+2.2%/yr |
| Ear tubes & middle ear surgery | 2 | 174−10%/yr | −10%/yr | 0.41.2× | 18% | 190 in 2030+1.3%/yr |
| Sleep apnea & airway implants | 3 | 122+0.3%/yr | +0.3%/yr | 0.31.1× | 0% | 70 in 2030−7.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 49 | 3,005−2.2%/yr | −2.2%/yr | 7.01.0× | 6% | 3,430 in 2030+2.2%/yr |
| Tumor & fibroid embolization | 1 | 248+17%/yr | +17%/yr | 0.50.9× | 79% | 1,090 in 2030+28%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 110 | 12,522+26%/yr | +26%/yr | 26.81.0× | 83% | 22,100 in 2030+9.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 43 | 2,124−7.2%/yr | −7.2%/yr | 4.80.9× | 0% | 1,980 in 2030−1.2%/yr |
| EP ablation | 30 | 1,317+6.3%/yr | +6.3%/yr | 2.40.6× | 0% | 2,610 in 2030+12%/yr |
| LAA occlusion & loop recorders | 42 | 1,148+5.9%/yr | +5.9%/yr | 2.20.6× | 0% | 2,100 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 96 | 3,828−8.3%/yr | −8.3%/yr | 6.71.1× | 0% | 3,340 in 2030−2.2%/yr |
| Structural heart (TAVR, TEER) | 40 | 718+4.9%/yr | +4.9%/yr | 1.30.8× | 0% | 940 in 2030+4.5%/yr |
| Mechanical circulatory support | 0 | 264−6.4%/yr | −6.4%/yr | 0.61.0× | 0% | 220 in 2030−2.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 9 | 226+16%/yr | +16%/yr | 0.51.1× | 0% | 310 in 2030+5.4%/yr |
| Stroke thrombectomy | 7 | 209+7%/yr | +7%/yr | 0.51.1× | 0% | 340 in 2030+8.4%/yr |
| DBS & VNS | 5 | 203−3.5%/yr | −3.5%/yr | 0.41.4× | 0% | 330 in 2030+8.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 91 | 27,713−3.2%/yr | −3.2%/yr | 59.31.0× | 80% | 29,700 in 2030+1.2%/yr |
| Vitreoretinal surgery | 16 | 944−6.8%/yr | −6.8%/yr | 2.10.8× | 85% | 910 in 2030−0.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 300 | 54,179−6.2%/yr | −6.2%/yr | 123.01.1× | 25% | 51,300 in 2030−0.9%/yr |
| Bronchoscopy & lung nodule | 40 | 2,343+2.3%/yr | +2.3%/yr | 5.21.6× | 0% | 4,370 in 2030+11%/yr |
| ERCP & endoscopic ultrasound | 24 | 1,609−3%/yr | −3%/yr | 3.61.1× | 2% | 1,660 in 2030+0.5%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.